skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Wednesday, December 25, 2013

Merry Christmas!


Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog

The Exemptee Institute
The Designated Representative Institute

The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 4:32 AM

No comments:

Post a Comment

Newer Post Older Post Home
View mobile version
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • FierceBiotech
    Novartis' B cell-depleting antibody fails to show promise in phase 2 dermatology study
    16 minutes ago
  • Science-Based Medicine
    Your terrain, your fault? Germ Theory Denial 2025
    45 minutes ago
  • Drug & Device Law
    A Major Expert Reset In Delaware
    1 hour ago
  • Medscape Today Headlines
    Workplace Burnout: Lessons From Professional Cycling
    1 hour ago
  • Government Executive
    OPM urges ‘generous approach’ to approving religion-based telework
    1 hour ago
  • Medtech Insight
    EU Authorities Unite In Call For Urgent Overhaul Of Medtech Regulations
    1 hour ago
  • Wellness Blog - NY Times
    My Memory Loss Is Affecting My Relationship
    2 hours ago
  • NPR Blogs: Shots - Health News Blog
    Maryland taps Affordable Care Act fund to help pay for abortion care
    2 hours ago
  • All Kaiser Health News
    Maybe It’s Not Just Aging. Maybe It’s Anemia.
    2 hours ago
  • GEN Biotech News
    Sarepta Axes 500, 36% of Workforce, in Restructuring after DMD Patient Deaths
    8 hours ago
  • BioPharma Dive - Latest News
    Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks
    15 hours ago
  • BioPharma Dive
    Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks
    15 hours ago
  • Pharmaceutical Commerce
    Thermo Fisher, Sanofi Expand Partnership to Boost Sterile Drug Production
    16 hours ago
  • FierceBiotech: Medtech
    Johnson & Johnson boosts financial projections with growing cardiac device sales
    17 hours ago
  • FDA What's New: Drugs
    Clean Solutions LLC - 686995 - 09/06/2024
    17 hours ago
  • CNBC Health Care
    Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
    18 hours ago
  • eLearning Industry
    The ESL Edge: What AI Can And Cannot Do For English Learners In Business Contexts
    18 hours ago
  • FDA - Press Releases
    FDA to Revoke 52 Obsolete Standards of Identity for Food Products
    20 hours ago
  • Pharmalot – STAT
    STAT+: Pharmalittle: We’re reading about Trump and pharma tariffs, an abortion pill ruling, and more
    22 hours ago
  • Clarkston Consulting
    Adhering to LabWare’s LIMS Basic Coding Standards
    23 hours ago
  • FiercePharma
    For Lundbeck and Otsuka's PTSD filing, FDA questions Rexulti efficacy after failed phase 3
    1 day ago
  • Pharmafile
    FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
    1 day ago
  • JD Supra Law News
    AGG Supports GHA and MAG in Latest Successful Step to Cap Wrongful Death Damages
    1 day ago
  • Drug Channels
    Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low
    2 days ago
  • Food Poison Journal
    Enoki Mushrooms recalled again due to Listeria
    3 days ago
  • Marler Blog
    FDA announces investigations into Salmonella, E. coli and Hepatitis A Outbreaks with no sources
    4 days ago
  • World Pharma - Breaking News
    Researchers develop potent CDK9 inhibitor to overcome drug resistance in hematological malignancies
    6 days ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    1 week ago
  • Healthcare Packaging
    Study Reveals the U.S. Pharmaceutical Firms with the Most FDA Recalls
    1 week ago
  • Pharmafile - Mfg & Production
    LEO Pharma appoints Helle Hedegaard Juhl as EVP of global people & corporate affairs
    1 week ago
  • The Incidental Economist
    Older Americans Backing Trump Now Face Cuts to Medicaid, Services
    2 weeks ago
  • Asbestos and Mesothelioma News
    Asbestos Ban Future Is Uncertain
    3 weeks ago
  • Clinical Correlations
    How Can We Better Protect Our Patients Against Extreme Heat?
    3 weeks ago
  • Ted Eytan, MD
    Nova Exhibition
    3 weeks ago
  • The Compliance and Ethics Blog
    Mark Diamond on Rethinking Records Retention [Podcast]
    4 weeks ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    5 weeks ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    5 weeks ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    1 month ago
  • Quality Matters
    A path to locally manufactured quality medicines: Building capacity in Africa to conduct bioequivalence studies
    1 month ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    3 months ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    4 months ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    4 months ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    5 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    5 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    5 months ago
  • 33 Charts
    AI and LinkedIn Writing as a Commodity
    5 months ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    6 months ago
  • FDA - Health Fraud
    27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
    9 months ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    11 months ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    1 year ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    1 year ago
  • Medgadget
    Plant-Based Soft Medical Robots
    1 year ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    1 year ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    1 year ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    2 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    2 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    2 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    5 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ►  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ▼  2013 (127)
    • ▼  December (7)
      • Merry Christmas!
      • Report: Christmas will kill you | National Monitor
      • We Moved Forward on Many Fronts This Year | FDA Voice
      • Expert Panel Want BP Cuffs Loosened - MedPage Today
      • FDA Drug Quality and Security Act Stakeholder Disc...
      • Procedure Writing Course
      • Nanotech Roundup: Latest National Nanotechnology I...
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo